Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of Yi-Ke-Ding Tablets for chronic cholecystitis with dampness-heat syndrome
ChiCTR-IPR-14005428Phase 3Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Oct 2010
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Yi-Ke-Ding Tablets in chronic cholecystitis (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: VAS score of right hypochondriac pain. Started Oct 2010; status: completed.
02
Drugs
Yi-Ke-Ding Tablets
03
Conditions
chronic cholecystitis
Beyond the preview
Go deeper on ChiCTR-IPR-14005428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-14005428.